Article
AI-Enabled Prediction of Homologous Recombination Deficiency from Histopathology Images
2025-06-19
Abstract excerpt
Identification of patients who will respond to Poly (ADP-ribose) polymerase (PARP) in-hibitor therapy is challenging due to the lack of a unifying morphological pheno-type. Homologous recombination deficiency (HRD), a key biomarker in breast and ovarian cancer, guides therapeutic decisions. Current HRD testing via next-generation sequencing (NGS) is tissue-dependent, has high failure rates, misses relevant HRD gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e0e38696-5f30-56db-90fd-a7fc2a0483ed
- DOI
- 10.20944/preprints202506.1556.v1
